32. Thompson CC et al. Am J Gastroenterol. 2017;112:447-57.
33. SAGES abstract archives. SAGES. Available from: http://www.sages.org/meetings/annual-meeting/abstracts-archive/first-clinical-experience-with-the-transpyloric-shuttle-tpsr-device-a-non-surgical-endoscopic treatment-for-obesity-results-from-a-3-month-and-6-month-study. Accessed Sept. 12, 2018.
34. Sjostrom L et al. N Engl J Med. 2007;357:741-52.
35. Adams TD et al. N Engl J Med. 2017;377:1143-55.
36. Abu Dayyeh BK et al. Clin Gastroenterol Hepatol. 2011;9:228-33.
37. Thompson CC et al. Gastroenterology. 2013;145(1):129-37.
38. Jirapinyo P et al. Endoscopy. 2018;50(4):371-7.
39. Kumar N, Thompson CC. Gastrointest Endosc. 2016;83(4):776-9.
40. Jirapinyo P et al. Gastrointest Endosc. 2017;85(5):AB93-94.
41. Jirapinyo P, Thompson CC et al. Comparison of a novel plication technique to suturing for endoscopic outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Obesity Week 2018. Poster presentation.
42. Kaplan LM et al. EndoBarrier therapy is associated with glycemic improvement, weight loss and safety issues in patients with obesity and type 2 diabetes on oral anti-hyperglycemic agents (The ENDO Trial). In: Oral Presentation at the 76th American Diabetes Association (ADA) Annual Meeting: 2016 June 10-14: New Orleans. Abstract number 362-LB.
43. Jirapinyo P et al. Diabetes Care. 2018;41(5):1106-15.
44. Rajagopalan H et al. Diabetes Care. 2016;39(12):2254-61.
45. Sandler BJ et al. Surgical Endosc. 2015;29:3298-303.
46. Machytka E et al. Gastrointest Endosc. 2017;86(5):904-12.
